LENALIDOMIDE/LOW-DOSE DEXAMETHASONE IN COMBINATION WITH CONTINUOUS ORAL CYCLOPHOSPHAMIDE COMPARED TO LENALIDOMIDE/LOW-DOSE DEXAMETHASONE COMBINED WITH SINGLE CYCLOPHOSPHAMIDE DOSES IV IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: